Invention Grant
- Patent Title: Fused pyrazole derivatives as novel ERK inhibitors
- Patent Title (中): 融合吡唑衍生物作为新型ERK抑制剂
-
Application No.: US13821149Application Date: 2011-09-12
-
Publication No.: US09242981B2Publication Date: 2016-01-26
- Inventor: Gerald W. Shipps, Jr. , Yongqi Deng , Alan B. Cooper , Xiaolei Gao , Binyuam Sun , James Wang , Liang Zhu
- Applicant: Gerald W. Shipps, Jr. , Yongqi Deng , Alan B. Cooper , Xiaolei Gao , Binyuam Sun , James Wang , Liang Zhu
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Richard S. Parr; Laura M. Ginkel
- International Application: PCT/US2011/051149 WO 20110912
- International Announcement: WO2012/036997 WO 20120322
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02 ; C07D471/04 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D417/14 ; C07D519/00 ; C07D405/04
Abstract:
Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and the pharmaceutically acceptable salts thereof. All substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (I).
Public/Granted literature
- US20130172341A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS Public/Granted day:2013-07-04
Information query
